Supriya Lifescience Limited (SUPRIYA) - Total Liabilities

Latest as of September 2025: Rs1.21 Billion INR ≈ $13.10 Million USD

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has total liabilities worth Rs1.21 Billion INR (≈ $13.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Supriya Lifescience Limited (SUPRIYA) cash flow conversion to assess how effectively this company generates cash.

Supriya Lifescience Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's total liabilities have evolved over time, based on quarterly financial data. Check SUPRIYA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Supriya Lifescience Limited Competitors by Total Liabilities

The table below lists competitors of Supriya Lifescience Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Poly Union Chemical Holding Group Co Ltd SHE:002037	China	CN¥14.05 Billion
Tipco Asphalt Public Company Limited F:NVP5	Germany	€8.25 Billion
Jiangxi Huawu Brake Co Ltd SHE:300095	China	CN¥1.50 Billion
PWR Holdings Ltd AU:PWH	Australia	AU$88.11 Million
Biglari Holdings Inc NYSE:BH	USA	$525.71 Million
Northpointe Bancshares, Inc. NYSE:NPB	USA	$6.45 Billion
Hamaton Automotive Technology Co Ltd SHE:300643	China	CN¥272.37 Million
Sun International Ltd JSE:SUI	South Africa	ZAC9.98 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Supriya Lifescience Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SUPRIYA company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Supriya Lifescience Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Supriya Lifescience Limited (2018–2025)

The table below shows the annual total liabilities of Supriya Lifescience Limited from 2018 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs1.16 Billion ≈ $12.50 Million	+9.15%
2024-03-31	Rs1.06 Billion ≈ $11.45 Million	-12.37%
2023-03-31	Rs1.21 Billion ≈ $13.07 Million	+1.46%
2022-03-31	Rs1.19 Billion ≈ $12.88 Million	-32.68%
2021-03-31	Rs1.77 Billion ≈ $19.13 Million	-5.53%
2020-03-31	Rs1.87 Billion ≈ $20.25 Million	+17.57%
2019-03-31	Rs1.59 Billion ≈ $17.22 Million	-16.50%
2018-03-31	Rs1.91 Billion ≈ $20.63 Million	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$604.83 Million

Rs55.93 Billion INR

Market Cap Rank

#11566 Global

#547 in India

Share Price

Rs694.90

Change (1 day)

-0.48%

52-Week Range

Rs553.35 - Rs802.65

All Time High

Rs806.85